• Citer

Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.

par Fiocca, R;Mastracci, L;Attwood, S E;Ell, C.;Galmiche, Jean-Paul;Hatlebakk, J;Bärthel, A;Långström, G;Lind, T;Lundell, L;Devière, Jacques
Référence Alimentary pharmacology & therapeutics, 36, 10, page (959-971)
Publication Publié, 2012-11

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
Auteur:	Fiocca, R; Mastracci, L; Attwood, S E; Ell, C.; Galmiche, Jean-Paul; Hatlebakk, J; Bärthel, A; Långström, G; Lind, T; Lundell, L; Devière, Jacques
Informations sur la publication:	Alimentary pharmacology & therapeutics, 36, 10, page (959-971)
Statut de publication:	Publié, 2012-11
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adolescent
	Adult
	Aged
	Anti-Ulcer Agents -- therapeutic use
	Chromogranin A -- blood
	Enterochromaffin-like Cells -- metabolism -- pathology
	Esomeprazole -- therapeutic use
	Female
	Follow-Up Studies
	Gastric Acid -- metabolism
	Gastric Mucosa -- drug effects -- metabolism
	Gastrins -- blood
	Gastroesophageal Reflux -- complications -- drug therapy
	Helicobacter Infections -- complications -- drug therapy
	Helicobacter pylori -- isolation & purification
	Humans
	Laparoscopy
	Male
	Middle Aged
	Proton Pump Inhibitors -- therapeutic use
	Time Factors
	Treatment Outcome
	Young Adult
Note générale:	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
	FLWIN
Langue:	Anglais
Identificateurs:	urn:issn:0269-2813
	info:doi/10.1111/apt.12052
	info:pmid/22998687